Cargando…
COVID-19 and its implications for thrombosis and anticoagulation
Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-induced infection can be associated with a coagulopathy, findings consistent with infection-induced inflammatory changes as observed in patients with disseminated intravascular coagulopathy (DIC). The lack of prior...
Autores principales: | Connors, Jean M., Levy, Jerrold H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273827/ https://www.ncbi.nlm.nih.gov/pubmed/32339221 http://dx.doi.org/10.1182/blood.2020006000 |
Ejemplares similares
-
Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis
por: Levy, Jerrold H., et al.
Publicado: (2020) -
Timing of anticoagulation for the management of portal vein thrombosis in liver cirrhosis
por: Valeriani, Emanuele, et al.
Publicado: (2023) -
Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020) -
Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination()()
por: Iba, Toshiaki, et al.
Publicado: (2022) -
The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
por: Al-Samkari, Hanny, et al.
Publicado: (2018)